Clinical Trials in San Francisco

Showing 7581-7600 of 12,991 trials

Valganciclovir to Reduce T Cell Activation in HIV Infection

NCT00264290

The purpose of this study is to determine whether treatment with valganciclovir decreases T cell activation levels among HIV-infected patients with asymptomatic cytomegalovirus (CMV) co-infection, potentially improving immune responses to antiretroviral therapy.

HIV InfectionsCytomegalovirus Infections

University of California, San Francisco30 participantsStarted Aug 2006

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

NCT00064129

This phase I trial is studying the side effects and best dose of ipilimumab when given with sargramostim in treating patients with metastatic prostate cancer. Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Colony-stimulating factors, such as sargramostim, may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system kill more tumor cells.

Recurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7

National Cancer Institute (NCI)42 participantsStarted May 2003

San Francisco, California, United States

COMPLETED< 1 mile

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

NCT03539562

This will be a prospective study on labor characteristics, and obstetric and neonatal outcomes in women who accept and women who decline morphine as a form of pain management in labor. The study will also investigate patient satisfaction with this form of analgesia. The participants will be those who accept morphine and promethazine and those who decline morphine and promethazine for pain control.

Labor PainEarly Labor

University of California, San Francisco82 participantsStarted Sep 2017

San Francisco, California, United States

Valganciclovir to Reduce T Cell Activation in HIV Infection

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

Find Trials by Condition in San Francisco

Study of Urate Elevation in Parkinson's Disease, Phase 3

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Clinical Evaluation of Daily Disposable Contact Lenses

A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses

Treatment for CI-DME in Eyes With Very Good VA Study

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis

Genomic Analysis of Pediatric Bone Tumors

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

PREMIUM Migraine Trial

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

Multi-Center Study of New Medications to Treat Vaginal Infections